References
- 1. C. L. Bowlus, M.E.Gershwin – The Diagnosis of Primary Biliary Cirrhosis, Autoimmunity Reviews, Volume 13, Issues 4 – 5, April – May 2014, pg.441 - 444.10.1016/j.autrev.2014.01.041398774524424173
- 2. S. C. Hauser, D. S. Pardi, J. J. Poterucha – Mayo Clinic Gastroenterology and Hepatology Board Review, Third Edition, Mayo Clinic Scientific Press And Informa Healthcare USA, Inc, 2008, Rochester, MN, pg.377-38110.1201/b14432
- 3. K. D. Lindor,M. E. Gershwin, R. Poupon, M. Kaplan, N. V. Bergasa, and E. J. Heathcote – Primary biliary cirrhosis, AASLD Hepatology, AASLD Practice Guidelines, Volume 50, Issue 1, 2009, pg.291 – 308.10.1002/hep.2290619554543
- 4. N. Bekki, S. K. Bae, S. Yoshizawa, A. Shiota, T. Gushima, J. Motoshita, S. Shimoda, Y. Aiba, A. Komori, M. Nakamura, K. Takahashi – A case of primary biliary cirrhosis in a patient with rheumatoid arthritis, Clinical Case Reports 2016; Volume 4, Issue 1, pg. 90–9410.1002/ccr3.449470641026783445
- 5. S. Abraham, S. Begum, D. Isenberg – Hepatic manifestations of autoimmune rheumatic diseases, Annals of the Rheumatic Diseases, 2004, Volume 63, Issue 2, pg.123–129.10.1136/ard.2002.001826175490114722198
- 6. C. Caramella, J. Avouac, Ph. Sogni, X. Puéchal, A. Kahan, Y. Allanore – Case report: Association between rheumatoid arthritis and primary biliary cirrhosis, Joint Bone Spine 2007, 74(3), pg.279 – 28110.1016/j.jbspin.2006.06.01217369071
- 7. Reumatológia Jegyzet, Prof.Dr.Lia Georgescu, Litografia UMF Tirgu Mures, 2010, pg. 152 – 170
- 8. S. Gonzaler-Roces, M. V. Alvarez,S. Gonzalez, A. Dieye, H. Makni, 0. G. Woodfield, L. Housan, V. Konenkov, M. C. Abbadi, N. Grunneta, E. Cotol, C. Lopez-tarreal - HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis, Tissue Antigens, Volume 49,Issue 2,1997, pg. 116–123.10.1111/j.1399-0039.1997.tb02724.x9062966
- 9. C.A. Vargas, R. Medina, C.E. Rubio, E.A. Torres – Primary biliary cirrrhosis associated with Ankylosing spondylitis, Journal of Clinical Gastroenterology, 1994, 18(3), pg.263 – 264.10.1097/00004836-199404000-000328034941
- 10. J. Zochling, D. van der Heijde, R. Burgos-Vargas, E. Collantes, J. C. Davis Jr, B. Dijkmans, M. Dougados, P. Ge´her, R. D. Inman, M. A. Khan, T. K. Kvien, M. Leirisalo- Repo, I. Olivieri, K. Pavelka, J. Sieper, G. Stucki, R. D. Sturrock, S. van der Linden, D. Wendling, H. Bo¨hm, B. J. van Royen, J. Braun – ASAS/EULAR recommendations for themanagement of ankylosing spondylitis, Annals of the Rheumatic Diseases, 2006;65(4), pg:442 – 452.
- 11. J. Braun, R. van den Berg, X. Baraliakos, H. Boehm, R. Burgos-Vargas, E. Collantes-Estevez, H. Dagfi nrud, B. Dijkmans, M. Dougados, P. Emery, P. Geher, M. Hammoudeh, R.D. Inman, M. Jongkees, M.A. Khan, U. Kiltz, T.K. Kvien, M. Leirisalo-Repo,W.P. Maksymowych, I. Olivieri, K. Pavelka, J. Sieper, E. Stanislawska-Biernat, D. Wendling, S. Özgocmen, C van Drogen, B.J. van Royen, D. van der Heijde - 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis, Annals of the Rheumatic Diseases, 2011;Volume 70, Issue 6, pg.896 – 904.10.1136/ard.2011.151027308605221540199
- 12. C.L. Kohema, A. B. Bortoluzzob, C. R. Gonçalvesc, J. A. Braga da Silvad, A. C. Ximenese, M. B. Bértolo f, S.L.E. Ribeirog, M. Keisermanh, R. Menini, T. L. Skarej, S. Carneirok, V. F. Azevedol, W. P. Vieiram, E. N. Albuquerquen, W. A. Bianchio, R. Bonfigliolip, C. Campanholoq, H. M. S. Carvalhor, I. Pereira da Costas, A. L. B. Pinto Duartet, N. H. Leiteu, S. A. L. Limaw, E. S. Meirellesx, I. A. Pereiray, M. M. Pinheiroz, E. Polito, G. G. Resende, F. A. C. Rocha, M. B. Santiago,M. de Fátima L. C. Sauma, V. Valim, P. D. Sampaio-Barros - Profile of the use of disease modifying drugs in the Brazilian Registry of Spondyloarthritides, Revista Brasileira de Reumatologia, 2013, 54(1), pg.33 – 37.10.1016/j.rbre.2014.02.004
- 13. S. L. Taffet, K. M. Das – Sulfasalazine. Adverse effects desensitization, 1983, Volume 28, Issue 9, pg. 833 – 842.10.1007/BF012969076136396
- 14. G. P. Aithal - Hepatotoxicity related to antirheumatic drugs, Nature Reviews Rheumatology, 2011, Volume 7, pg. 139 – 150.10.1038/nrrheum.2010.21421263458
- 15. A. Pandit, T. Sachdeva, P. Bafna – Drug – Induced Hepatotoxicity: A Review, Journal of Applied Pharmaceutical Science 2012, 02 (05); pg.233-24310.7324/JAPS.2012.2541
- 16. P. Jobanputra, R. Amarasena, F. Maggs, D. Homer, S. Bowman, E. Rankin, A. Filer, K. Raza, R. Jubb - Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: A case series from a local surveillance of serious adverse events, BMC Musculoskeletal Disorders 2008, 9:48.10.1186/1471-2474-9-48232963218405372
- 17. R. Ionescu – Esenţialul în reumatologie, capitolul Spondilita anchilozantă, ed.Amaltea, Bucureşti, 2007, pg.281 – 292.
- 18. Szekanecz Z. – Reumatológiai gyógyszeres terápia, EdituraMedicina, Budapesta, 2009, pg. 75 – 76.